Malaysian Genomics to market 'GenomeCheck' testing services in SEA


KUALA LUMPUR: Malaysian Genomics Resources Centre Bhd has entered into a distribution agreement with South Korea's Dx&Vx Co Ltd in a collaboration to ensure the smooth market entry of GenomeCheck, the latter company's genome testing services, in Southeast Asia.

In a filing with Bursa Malaysia, MGRC said it will be responsible for transporting the collected specimens to the designated testing locations using appropriate methods.

It will also be responsible for the development and expansion of the market through vigorous promotional and sales activities.

DxVx, meanwhile, will commit to providing the necessary promotional and academic materials to support

MGRCT advertising and sales activities.

The agreement shall be valid from June 28, 2024, until June 27, 2025, which unless terminated by either party, will be automatically extended for another year.

Get 20% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 11.12/month

Billed as RM 11.12 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 9.87/month

Billed as RM 118.40 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
MGRC , genomics , Dx&Vx , GenomeCheck

Next In Business News

Destini's RAILTEC bags RM45.58mil RAC contract
Bursa Malaysia's key index ends higher on bargain-hunting
TNB, Air Selangor team up to enhance country's energy and water infrastructure
Oriental Interest expands income stream with RM280mil acquisitions
SNS Network scores record RM1.22bil contract for the supply of servers
CapitaLand Malaysia records higher net profit of RM44mil in 2Q
Wall St futures rise as US, Iran pause hostilities
OCBC Malaysia, CGC launch RM1.3bil guarantee facility to boost SME financing
Malaysia must build future-ready workforce to capitalise on Asia's economic rise
FBM KLCI mirrors upbeat regional performance

Others Also Read